Last mentioned: 2h ago
NIN Integration
Planned full integration of health insurance status with National Identification Numbers.
Enforcement Announcement
Federal Government announces strict enforcement measures as OOP spending hits 71%.
Rollout Milestone
Acoziborole enters the final stages of regulatory rollout for endemic regions.
Vulnerable Group Fund Launch
Initial funding allocated to cover the poorest segments of the population.
NHIA Act Signed
President signs the National Health Insurance Authority Act, making insurance mandatory.
Trial Results
Phase 2/3 clinical trial results for Acoziborole show high efficacy.
Fexinidazole Approval
First all-oral 10-day treatment for sleeping sickness is approved.
Research Begins
DNDi starts screening compounds for a single-dose HAT treatment.
The introduction of Acoziborole, a single-dose oral medication, marks a pivotal shift in the global fight against Human African Trypanosomiasis. This breakthrough treatment simplifies complex therapeutic regimens, potentially enabling the total elimination of the disease by 2030.
Preliminary CDC data indicates that the 2025-2026 influenza vaccine provided lower-than-expected protection, with effectiveness falling to approximately 32%. The findings highlight a significant mismatch between the vaccine's composition and the dominant H3N2 variant, sparking calls for faster manufacturing platforms.
The Nigerian Federal Government has moved to strictly enforce mandatory health insurance for all citizens and residents as out-of-pocket healthcare spending reaches a staggering 71%. This regulatory pivot aims to mitigate medical poverty and accelerate the nation's progress toward Universal Health Coverage.
A significant uptick in tobacco consumption is creating a dual crisis for India, escalating public health expenditures while threatening long-term economic productivity. The surge highlights a critical gap in current regulatory frameworks and preventive healthcare strategies.